IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2.

Miller JP, Kim KK, Snyder CW, Khazan N, Singh NA, Boyer ME, Lamere E, Strawderman M, Sharma S, Lakony R, Whittum M, Anderson M, Keenan R, Pritchett E, Baker C, Ashton J, Khera MK, Elliott MR, Annunziata CM, Bajaj J, Calvi LM, Becker MW, Rowswell-Turner R, Moore RG, Singh RK

Open source

DOI: 10.64898/2026.04.30.722105
Published: 2026 May 5
Container: bioRxiv : the preprint server for biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.04.30.722105,
  title = {IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2.},
  author = {Miller JP and Kim KK and Snyder CW and Khazan N and Singh NA and Boyer ME and Lamere E and Strawderman M and Sharma S and Lakony R and Whittum M and Anderson M and Keenan R and Pritchett E and Baker C and Ashton J and Khera MK and Elliott MR and Annunziata CM and Bajaj J and Calvi LM and Becker MW and Rowswell-Turner R and Moore RG and Singh RK},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.04.30.722105},
  url = {https://doi.org/10.64898/2026.04.30.722105}
}

RIS

TY  - JOUR
TI  - IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2.
AU  - Miller JP
AU  - Kim KK
AU  - Snyder CW
AU  - Khazan N
AU  - Singh NA
AU  - Boyer ME
AU  - Lamere E
AU  - Strawderman M
AU  - Sharma S
AU  - Lakony R
AU  - Whittum M
AU  - Anderson M
AU  - Keenan R
AU  - Pritchett E
AU  - Baker C
AU  - Ashton J
AU  - Khera MK
AU  - Elliott MR
AU  - Annunziata CM
AU  - Bajaj J
AU  - Calvi LM
AU  - Becker MW
AU  - Rowswell-Turner R
AU  - Moore RG
AU  - Singh RK
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.04.30.722105
UR  - https://doi.org/10.64898/2026.04.30.722105
ER  -

APA

JP, M., KK, K., CW, S., N, K., NA, S., ME, B., E, L., M, S., S, S., R, L., M, W., M, A., R, K., E, P., C, B., J, A., MK, K., MR, E., CM, A., J, B., LM, C., MW, B., R, R., RG, M., & RK, S. (2026). IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.04.30.722105

Source records

pubmed · retrieved 2026-09-26T22:58:19.497Z
europe-pmc · retrieved 2026-09-26T22:58:19.517Z